Perimenopause, also known as “Menopausal transition” is the transitional phase before menopause. Menopause typically occurs ...

May is Bladder Cancer Awareness Month and at Frontiers in Oncology, we are dedicated to spotlighting the groundbreaking discoveries transforming the ...

INX-315, a CDK2 inhibitor, gained FDA fast track status in CCNE1-positive platinum-resistant/refractory ovarian cancer.

Northwestern Medicine scientists have identified a key driver of chemotherapy resistance in advanced ovarian cancer, ...

In general, cancer incidence is projected to rise significantly, with global cases expected to increase by 20% by 2030 and ...

Breast cancer deaths among women ages 20-49 declined significantly between 2010 and 2020, according to a new study.

ALMOST one in three women have put off seeing their GP about worrying gynaecological symptoms that could be signs of cancer, ...

A Preston woman, diagnosed with ovarian cancer when her first grandchild was only nine days old, shared how she felt guilty ...